BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

AIM Vaccine Advances High Efficiency Diploid Rabies Vaccine Into Final Clinical Stage

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficie...

January 19, 2026 | News

Hyundai BioScience Sets Out A Pre Emptive Antiviral Play To Tackle Multiple Viruses With One Drug

- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks...

January 19, 2026 | News

Antengene Showcases Next Phase Of Global Innovation At J P Morgan Healthcare Conference

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, develop...

January 19, 2026 | News

Aptar Powers Intranasal Covid Vaccine Trial With LuerVax And Spray Divider Delivery Systems

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, announced that its inno...

January 15, 2026 | News

Clover Advances Global First In Class Respiratory Vaccine Strategy With Phase Two Launch

- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candid...

January 13, 2026 | News

Sanofi To Acquire Dynavax For $15.50 Per Share In $2.2 Billion All Cash Deal

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price onDecember 23, 2025 Sanofi announced that it has entered into...

January 02, 2026 | News

Intas Pharmaceuticals Limited Secures Exclusive Needle Free Injection Technology For IVF And Gynecology In India

Intas Pharmaceuticals Limited (“Intas”), a leading multinational pharmaceutical company, has entered into an exclusive agreement with ...

December 30, 2025 | News

BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025

The year 2025 has marked a pivotal moment for the biopharmaceutical industry as it reckons with the aftershocks of a global pandemic and ongoing geopolitic...

December 24, 2025 | Analysis

GC Biopharma Secures MFDS Approval For Phase 1 Trial Of mRNA Covid 19 Vaccine Candidate

Phase 2 IND submission targeted for the second half of 2026- Demonstrating the competitiveness of GC Biopharma's mRNA platform GC Biopharma (...

December 24, 2025 | News

Qihan Biotech Initiates Phase I IIa Dosing Of Allogeneic CAR T Therapy For Refractory Lupus

Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-...

December 22, 2025 | News

GC Biopharma Ships World First Recombinant Anthrax Vaccine For National Stockpile

GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced the first shipment of BARYTHRAX inj., the world's first recombinant a...

December 09, 2025 | News

Sabin Vaccine Institute Sends 640+ Investigational cAd3-Marburg Vaccine Doses to Ethiopia for Rapid Outbreak Response

The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia to support the country’s res...

December 08, 2025 | News

Replicate Bioscience Partners With Instituto Butantan To Advance Next Generation srRNA Rabies Vaccine Across Latin America

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunol...

December 05, 2025 | News

GC Biopharma Achieves WHO Recognition for MAV Zero Six Varicella Vaccine Strain

Officially recognized by WHO as a standard varicella vaccine strain alongside Oka Interchangeability endorsed, enhancing global supply securit...

December 03, 2025 | News

Stay Connected